北京军区总医院的自体干细胞移植做广告，可恨的骗子。

云帆风影888

路透社的报道百度现在还可以搜到

云帆风影888

中国干细胞疗法让人伤心欲绝


1
HONG KONG (Reuters) - Chinese hotel manager Hong Chun had trouble using chopsticks after a minor stroke and sought treatment at a large Shanghai hospital where doctors injected what they said were donor stem cells into his spinal cord and buttocks, according to his father and cousin.香港(路透社)——中国酒店的经理洪淳轻微中风,用筷子有困难,寻求治疗,根据他的父亲和堂兄陈述，上海医院医生在他的脊椎和臀部注射他们所称的供体干细胞。
Leaving hospital the next day, Hong, 27, fell so ill he had to be taken off the train and rushed to another hospital.第二天,离开医院,27日,洪淳出现头晕和恶心的症状，他只好走下火车,到另外一家医院治疗。But doctors were unable to save him and he was declared brain dead before dying a month later.但是医生无法拯救他,他被宣布脑死亡一个月后离世。
Desperate for help, patients with incurable diseases are admitting themselves into hospitals in China for "stem cell therapies" but experts say such treatments are backed by little or no scientific evidence and are at best experimental.监管空白的存在,客观上鼓励了医院“大胆尝试”。“干细胞疗法”,但专家称该治疗方法是以很少甚至没有任何科学证据和最好的实验。
Some of these cases involve large general hospitals where patients pay thousands, even tens of thousands, of dollars for treatments that are advertised online.这些病例都大型综合医院里病人成千上万,甚至支付数万美元的治疗,在线广告。Patients have come away with little or no improvement and a number have died, according to patients, doctors and relatives of patients who spoke to Reuters.病人病情很少或没有改进伴随大量死亡,根据患者,医生和病人的亲戚告诉路透社记者。
Hong paid 30,000 yuan ($4,800) to the Chinese army's 455 PLA Hospital in Shanghai for the treatment last year, according to hospital receipts seen by Reuters.洪淳付了30000元(4800美元)在上海中国人民解放军455军队医院进行治疗,根据医院去年收据路透社记者所看到的。
His father, Hong Gensho, travelled to Shanghai to seek an explanation.他的父亲,洪先生,Gensho前往上海寻求一个解释。But hospital administrators told him his son didn't die in their hospital, paid him 80,000 yuan and told him not to pursue the matter.但是医院管理者告诉他他的儿子没死在他们的医院,给他80000元,告诉他不要追再追究这件事了。
"I am miserable, it's like my son was worth only 80,000 yuan.“我很可怜的,就像我儿子在价值只有80000元。It's not about money.这不是钱的问题。Our human rights, our place in this society, are not respected.我们的地位决定我家在这个社会不被尊重。I am devastated.我真的很伤心。If he hadn't sought treatment, he would not have died," said the elder Hong, 61.如果他没有寻求治疗后,他就不会死,”61岁的洪先生说。
"I can't get my son back, but people must know about these stem cell therapies and no one must be deceived." “我不能让我的儿子复活，但是，人们必须知道这些干细胞治疗，不能再有人受到蒙蔽了。”
LACK OF SCIENTIFIC EVIDENCE缺乏科学证据
Experts have raised the alarm on patients turning up at clinics and hospitals in China, Mexico, India, Turkey, Russia and elsewhere for stem cell therapies that have not undergone clinical trials and which are not recognized as standard treatment.专家提出了报警对病人出现在诊所和医院在中国、墨西哥、印度、土耳其、俄罗斯和其他干细胞治疗,未经临床试验并没有公认的标准治疗。
Patients often pay fees of $20,000 and more for such therapies after exhausting conventional treatments.病人经常费用支付20000美元,但是更多的常规治疗,这些治疗方法。
"Stem cell tourism is regarded as ethically problematic because patients receive unproven therapies from untrustworthy sources," Dr David Resnik at the U.S. National Institute of Environmental Health Sciences and Zubin Master at the University of Alberta in Canada wrote in a paper published in the journal European Molecular Biology Organization.“干细胞旅游作为伦理问题的病人接受治疗因为未从不能信任的来源,”大卫Resnik博士在美国国家环境卫生科学研究所,硕士Zubin大学在加拿大亚伯达省写了一篇发表在《欧洲分子生物学组织》。
Echoing the same concerns, Dr George Daley at the Harvard Stem Cell Institute and Harvard Medical School said he was swamped by enquiries from patients asking about therapies in China and Brazil for diseases from Alzheimer's to spinal cord injuries.与相同的问题,乔治·戴利的哈佛大学博士干细胞研究所和哈佛大学医学院说他被询问询问病人治疗在中国和巴西的疾病,从阿尔茨海默氏病脊髓损伤。
"What I'm talking about are the less legitimate treatments that have not even undergone clinical trials but are directly marketed therapies...“我说的都是缺少合法性的治疗,甚至还没有经历了临床试验,但直接用于临床治疗…We really have no idea how to use stem cells for these treatments," Daley told Reuters.我们真的不知道如何使用干细胞,这些治疗方法,”戴利告诉路透社记者。
When contacted by Reuters, a director at the PLA 455 Hospital, who declined to be identified, said: "There are always good and bad outcomes.路透社,当接触的一位导演,中国人民解放军455医院不愿透露姓名的,说:"总有好的和坏的结果。No therapy can guarantee success to everyone...没有治疗可以保证成功到每一个人…Besides, you don't have a better alternative.除此之外,你没有一个更好的选择。
"As for patients dying, all deaths must be investigated.“至于患者死亡,死亡人数的行为,必须予以追究。What caused the death?什么导致了死亡?If our treatment caused the death, the patient (relatives) can seek redress.如果我们的治疗,病人致其死亡(亲戚)可以要求赔偿。If it is a death caused by old age and sickness, then there is nothing I can say."我只能说是由年老和死亡和疾病引起的。”
China's Ministry of Health did not respond to questions from Reuters on stem cell therapies being offered in the country.中国卫生部没有回应路透社提出的中国为什么允许干细胞治疗问题。
VICTIMS ARE THOSE FACING DEATH受害者正面临死亡
Suffering from late-stage liver cirrhosis caused by a lifelong hepatitis B virus infection, Fan Hongkun was led to believe her body would spontaneously grow a healthy liver once stem cells were transplanted.患有晚期肝硬化造成终生的B型肝炎病毒感染、范洪坤被广告宣传相信干细胞移植能让她的身体自然生长一个健康的肝。
"We saw the therapy advertised online and talked to the doctor over the phone.“因为我们看到了在线的广告疗法并给医生打电话。He said stem cells were like seeds, after being planted on a liver, they grow, divide and spread and finally form a healthy liver," said Fan's son, Zhou Junjie.他说,干细胞就像种子,移植到肝上、种子长不停地繁殖,最终形成一个健康的肝脏,“范洪坤的儿子周俊杰说。
Fan, 63, was so convinced, she admitted herself into Beijing Military General Hospital, whose website still carries information on the stem cell therapies it offers.范,63岁，她确信北京军区总医院网站上宣传的干细胞疗法能治疗她的病。
"My mother said the PLA (Chinese army) doesn't lie.“我的母亲说中国人民解放军(中国军队)不会说谎。That's why she trusted them," said Zhou.这就是为什么她信任他们所说的干细胞技术,”周说。
Doctors there took her off the drug lamivudine for four weeks to "prepare her for the stem cell therapy".医生们让她停止服用药物拉米夫定四个星期“准备为她干细胞疗法”。But she fell into a coma before doctors could treat her.但她在医院应诺的干细胞治疗前陷入昏迷。
Sold under the brand Epivir by GlaxoSmithKline Plc, lamivudine minimizes liver damage by blocking the hepatitis B virus from replicating.在市场上销售的品牌Epivir葛兰素史克,拉米夫定使肝损伤,通过阻断乙肝病毒的复制。Fan's family learnt later from other doctors that she suffered a sudden surge of the virus after she stopped her medication, which pushed her into a coma and killed her.范的亲人通过其他医生了解到,停止服用拉咪呋叮加重了她的病情并导致她去世。
According to documents seen by Reuters, her family sued the hospital, but the case was dismissed by a Chinese court.根据路透社记者所看到的文件,她的家人起诉医院,但案件由中国法院驳回。
When contacted, a doctor at the hospital, who declined to be identified, said the entire procedure to transplant stem cells into a patient's liver takes only a day.记者联系上这家医院,一个不愿透露姓名医生说，,移植干细胞到病人的肝一个人只需要一天。
"We extract the patient's bone marrow cells and isolate the stem cells, which are then inserted into the liver," said the doctor.“我们提取患者的骨髓细胞和隔离干细胞,然后插入到肝脏,”医生说。"...We extract bone marrow cells in the morning and in the afternoon we inject them (stem cells) into the liver.“……我们提取骨髓细胞在早上和下午我们将它们注射(干细胞)到肝脏。Yes, all it takes is a day.是的,所有需要做的是花一天的时间。Very fast."非常快。”
Advertisements for these treatments remain on the hospital's website.这些治疗的广告留在医院的网站。
In Ireland, many patients have returned from treatments abroad with no improvement, but they are less willing to talk.在爱尔兰,许多患者治疗在国外回来没有改进,但他们也不愿意说话。
"Virtually none will go on record to state they have been conned.“实际上没有人会继续的纪录表示他们已经之中。This is mainly because many patients have serious immediate health concerns and they need to focus on that," Stephen Sullivan, chief scientific officer of the Irish Stem Cell Foundation, told Reuters.这主要是因为很多病人有严重的健康问题,他们立即需要集中精力,”首席科学家斯蒂芬·沙利文爱尔兰干细胞基础,告诉路透社记者。
"Patients are also reluctant to come forward as they are embarrassed at spending lots of money against professional medical advice.“患者也不愿意站出来为他们花很多钱难堪与专业医疗咨询。Some patients will even claim improvement when there is no measurable improvement."一些人甚至宣称改进患者当没有可衡量的改善。"
POTENTIALLY POWERFUL潜在的强大的
Researchers believe regenerative medicine will be a powerful form of therapy in the future.研究人员相信再生医学将是一个有力的形式的治疗,在未来的。Stem cells are immature, master cells in the body that can grow into any kind of human cell or tissue.干细胞是未成熟的细胞在体内,主人可以生长成任何一种人体细胞或组织。Scientists are exploring how to use them to treat a variety of diseases and disorders, including cancer, diabetes and injuries.科学家正在探索如何利用这些来治疗各种疾病和神经紊乱性疾病,包括癌症、糖尿病及伤害。
But for now, they stress that only one type of stem cell therapy has been proven to work.但是现在,他们强调,只有一个类型的干细胞疗法已经被证明能够工作。
"Only bone marrow transplants for diseases such as leukemia, lymphoma are backed by solid evidence and are well-established clinical procedures.“只有骨髓移植疾病,如白血病、淋巴瘤是确凿的证据和是信誉良好的临床过程。The others are not up to that level," said David Siu, clinical associate professor at the cardiology division of Hong Kong's Queen Mary Hospital.其他人还没达到这个水平,”大卫说小、临床副教授划分的香港心脏病玛丽女王医院。
"There is evidence that certain stem cells can grow into new tissue but do they provide a therapeutic effect?“有证据指出,某些干细胞能发展成新组织,但他们是否提供一个治疗效果?We don't have the evidence yet.我们没有证据呢。Some are in clinical research."有些是在临床研究。”
For the conditions highlighted in this article - disability from strokes and liver cirrhosis - experts say there are no proven stem cell treatments.本文突出残疾中风和肝硬化-专家说，目前还没有有效的干细胞治疗。
In their paper, Resnik and Master said while most countries had rules governing research on people and medical malpractice, they did not apply directly to stem cell therapy.在论文中,Resnik说,大多数国家有规定人的研究和医疗事故，他们不能直接用干细胞进行治疗。When doctors encounter strict regimes, they can simply move to other countries with more permissive legal environments.当医生遇到严格的制度时，他们可以简单地转移到其他法律环境宽松的国家。
Experimental stem cell therapies, however, may be legitimately offered to patients, but these must be carried out within the framework of clinical trials that are approved by regulatory boards that ensure ethical standards are met.实验性干细胞疗法，但是，可合法地提供给患者，但这些必须的框架内进行的临床试验，经监管，确保道德标准得到满足。
"When experimental stem cell therapy is used on patients, it is not performed on an ad-hoc basis but within the framework of a proper clinical trial prepared beforehand," Siu said.“当实验干细胞疗法用于患者,但却不是一个特设的基础上进行的框架内,但一个适当的临床试验豫备,”小说。"It has to follow a rigorous methodology: what are the risks, what can and cannot be done?“这必须遵循严格的方法:什么是风险,什么可以做到,什么不可以做什么呢?If the results are negative, what are the rescue and safety measures?"如果结果是否定的，有什么救援和安全措施？”
Sullivan urged patients to be on the lookout for scams.沙利文提醒病人当心被欺骗。Suspicious signs include being asked for large sums of money up front, being told there are no risks, and being offered no post-therapy care.这些欺骗迹象包括被要求付出大笔的钱,被告知没有风险,并没有提供治疗后的护理。
post-therapy Patients should be told how they will be treated, what stem cells are used and where they come from.患者应该被告知他们将如何治疗,干细胞的使用程度,他们来自哪里。They should not accept any therapy based on hearsay, or without the treatment being validated at least in part by peer review, he said.他们不应该接受任何治疗基于传闻,或没有治疗验证的至少部分地是由于同行评审,他说。
Resnik and Master urged stem cell scientists, who have control over stem cell lines, to help stop these scams by not releasing such materials to doctors or clinics if they cannot produce proof of conducting a genuine clinical trial.Resnik和掌握敦促干细胞科学家,制止那些没有经过真正的的临床试验而进行的干细胞治疗。
"This would ensure that the stem cells and other materials are going to be used in the course of responsible biomedical research, a legally sanctioned clinical trial or in responsible medical innovation," they said.“这将确保干细胞和其他材料将在生物医学研究,在合法许可的临床试验或责任重大的医学创新的,”他们说。

云帆风影888

打开百度搜索，干细胞治疗百病的虚假广告还多得是，大家一定要小心。

云帆风影888

摊破浣溪沙·雨夜梦母亲
静夜眠难有扣窗，倏惊疑未看端详,
忽尔轻敲听不见，雨声狂。
似曲净心推入梦，慈亲欢聚旧时乡。
莫是上苍知我意，慰悲肠。

云帆风影

利欲熏心，虚张声势，包治百病，骗无休止。

云帆风影

国家药监局：武汉生物百白破疫苗不合格属偶发
7月31日，国家药监局新闻发言人就公众关注的武汉生物制品研究所有限责任公司（以下简称武汉生物）百白破疫苗介绍有关情况。

1.武汉生物百白破疫苗效价指标不合格是如何发现的，究竟是什么问题？

答：2017年，原国家食品药品监督管理总局中国食品药品检定研究院在国家药品抽检中发现，武汉生物生产的批号为201607050-2的百白破疫苗百日咳效价指标不符合标准规定，白喉、破伤风效价指标符合规定。有关信息已于2017年11月3日向社会公布。

经现场检查和企业回顾性分析，武汉生物该批次疫苗效价不合格的主要原因是分装设备短时间故障，导致待分装产品混悬液不均匀，属于偶发。

http://news.ifeng.com/a/20180731/59527552_0.shtml
骇人听闻，40万只疫苗不合格被轻描淡写成偶发，把人民的安危当作儿戏，只有被钱迷了心窍才会有这样无耻的托词。
当年我举报干细胞治疗虚假到药监局，纪检人员接电话恶狠狠问：“你想干啥？你到底想干啥？”而不是首先问患者受到的伤害。

云帆风影

七绝·无题
神州处处怒成涛，本杏多栽却尽妖。
更恨长摧向童子，莫非族敌是官曹？
医界，古称杏林，据《神仙传》卷十记载:"君异居山为人治病不取钱使人重病愈者，使栽杏五株，轻者一株，如此十年，计得十万余株，郁然成林

多年前《中国经济时报》总编包月阳因为签发了王克勤的《山西疫苗乱象调查》竟然被免职。

七绝·感假疫苗案罪择宽
疫假惊天罪择宽，别虽一字命知安。
君疑应看承恩著，妖自仙家究恶难。
生产、销售假药罪属重罪，可判死刑。而生产、销售劣药罪无死罪，且处罚较轻。假疫苗如同害命，危及民族安危，却被定为涉嫌生产、销售劣药罪予以批捕。
承恩著，指明朝吴承恩著写的《西游记》。

云帆风影

蒋锡培干细胞 奥思达的非法干细胞治疗 蒋锡培的干细胞之梦
2019-02-02 - 蒋锡培
央视曝光的无锡奥思达干细胞公司恰恰是犯了各种天下之大不违。

315节目中,无锡奥思达方面对暗访的记者宣称,该公司的干细胞产品主要治疗恶性肿瘤、心血管疾病,重大疑难杂症,以及抗衰老。"做过之后,眼睛就会特别亮"。
但随后的焦点访谈则爆出,昆明市民张英家庭在无锡奥思达公司的血泪遭遇:三年前,58岁的张英已经患有结肠癌晚期,经咨询后,无锡奥思达方面向张家进行推介:"一般的癌症根本没有问题。你这个病很有希望的,如果不来我们这里的就没救了。"同时告诉他们:"能治好。退一步说,最坏也可以带癌病生存,至少10年。"
结果,张英丈夫卖掉住了大半辈子的住房,凑得36万元,支付给无锡奥思达方面,用于三剂胚胎干细胞的注射。然而,短短三个月后,张英病情急转直下,最终去世。事后张英丈夫还欠下十多万元的外债。除张英家庭外,还有另一石家庄患者也向央视反映在无锡奥思达接受的干细胞治疗没有疗效。
2013年起拟定的《干细胞临床试验研究管理办法(试行)》核心指导原则之一是:"开展干细胞临床试验研究,不得向受试者收取费用,不得市场化运作,不得发布干细胞治疗广告。"

而无锡奥思达已经对干细胞治疗项目展开了大规模的市场化运作:每一剂12万元,最高18万元,年收入近亿,一分表格显示,2012年2月至6月,共有32人注射了123针胚胎干细胞。

正规的干细胞,是从试管中培养的未形成组织的细胞中提取,无锡奥思达工作人员在视频中称干细胞来源是"早期胚胎,两个月以内,一个是流产,还有人家不要的。"事实上,这种提取这种干细胞在国内是非法的,而且被禁止直接用到人身上。而无锡奥思达的方面的干细胞来源,实际上是从无锡某医院提供的流产胎儿身上获得。而且据中介介绍,上述提供给奥思达的流产胎儿,从未经过检验,不能确定事病死还是其它正常死亡。

《干细胞临床试验研究基地管理办法(试行)》主要指导原则之一:"干细胞临床试验研究必须在干细胞临床试验研究基地进行。"要想成为干细胞临床试验研究基地,需具备多种条件,核心之一:必须是三级甲等医院。

事实上,在无锡奥思达接受了干细胞治疗的张英家庭称,收到治疗费后,奥思达公司第二天把张英夫妇带到了无锡市滨湖区的一家社区医院(雪浪卫生院),在这里为张英进行胚胎干细胞治疗。从奥思达公司到雪浪卫生院,未向张英家庭提供任何治疗记录。

从上游的非法获取流产婴儿,到中间的非法宣传、高额收费,再到下游的社区医院的无记录行医,无锡奥思达暗地里已经形成了一整条极为严密的非法干细胞产业链。

据人民网报道,经央视曝光后,无锡当地已由卫生、工商、质监等部门组成联合调查组,进驻奥思达公司进行摸排调查。

蒋锡培的干细胞之梦

无锡奥思达及其干细胞业务,从2011年起,一直是蒋锡培在远东控股体系列反复宣传的一个项目,从旗下官方网站的各种讯息,已经可见一斑。

无锡奥思达全称是"奥思达干细胞有限公司"。工商资料显示,该公司成立于2009年5月20日,注册资本5000万元人民币,法定代表人周萱。

公司的主要经营范围包括:生物、生化制品的研究与开发;生物技术的开发、应用、推广及咨询服务;干细胞临床医学的技术开发、技术咨询、技术转让及推广应用服务;抗衰老技术的开发、转让、咨询;实验分析仪器、化学试剂的销售等。(上述经营范围中涉及专项审批的待批准后方可经营)。

关于干细胞的临床与试验,显然需要国家有关部门的审批。而当央视记者向无锡奥思达方面要求查看相关的保证文件时,无锡奥思达负责人表示:"从来没人找我们要过这东西。"

工商资料显示,在这家非法经营干细胞业务的公司背后,董事长兼总经理名叫周萱,而无锡首富蒋锡培目前仍是该公司的董事。

无锡奥思达公司总计有28名股东,其中包括26名自然人股东和2家法人股东。两家法人股东中,有一家赫然就是蒋锡培家族控股的远东控股集团有限公司。26名自然人股东中,有一名自然人蒋岳培,疑与蒋锡培兄弟是同一人。

知情人士对21世纪网透露,蒋锡培一直相信干细胞技术的神奇功效,2009年前后就想投资干细胞产业,远东控股最早接触的其实是一家注册地同样在无锡的博雅干细胞科技有限公司,但后来因为种种原因没能谈妥,接下来才投资了奥思达干细胞有限公司。

该知情人士表士,关于无锡奥思达的董事长周萱,有着留美的博士后背景,还入选为国家鼓励海外归国创新创业人才的"千人计划"成员。

从央视的曝光来看,无锡首富蒋锡培的投资的这个项目,目前已经突破了法律法规监管的红色地带。